Verano Holdings (VRNO) Other Non-Current Liabilities (2022 - 2026)
Verano Holdings (VRNO) reported Other Non-Current Liabilities of $156000.0 for Q1 2026, down 93.71% year-over-year from $2.5 million in Q1 2025, and down 42.22% quarter-over-quarter from $270000.0 in Q4 2025.
Verano Holdings (VRNO) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Other Non-Current Liabilities data on file, last reported at $156000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $156000.0, down 93.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $156000.0 (down 93.71% YoY), and the FY2025 annual result was $270000.0, down 85.87% from the prior year.
- Other Non-Current Liabilities slipped to $156000.0 in Q1 2026 per VRNO's latest filing, from $270000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $53.7 million in Q3 2022 and troughed at $156000.0 in Q1 2026.
- A 5-year average of $6.4 million and a median of $3.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities tumbled 95.75% in 2023, then jumped 649.41% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $6.0 million in 2022, then plunged by 95.75% to $255000.0 in 2023, then jumped by 649.41% to $1.9 million in 2024, then slumped by 85.87% to $270000.0 in 2025, then plunged by 42.22% to $156000.0 in 2026.
- Business Quant data shows VRNO's Other Non-Current Liabilities at $156000.0 in Q1 2026, $270000.0 in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | 270,000.00 |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 5.01 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Dec 31, 2023 | 255,000.00 |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 4.95 Mn |
| Mar 31, 2023 | 5.74 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 53.74 Mn |